Breaking News Instant updates and real-time market news.

ACB

Aurora Cannabis

$9.77 /

+0.28 (+2.95%)

, CGC

Canopy Growth

$27.32 /

+1.2 (+4.59%)

14:55
01/05/21
01/05
14:55
01/05/21
14:55

NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says

New York lawmakers representing nearly a third of the state Senate on Tuesday pre-filed a bill to legalize marijuana, Marijuana Moments' Kyle Jaeger reports. Sen. Liz Krueger and 18 co-sponsors filed the legislation, which is identical to a bill she sponsored last year and has now been referred to the Senate Finance Committee, the author notes. It would make it so adults 21 and older would be able to purchase cannabis and cultivate up to six plants for personal use, the publication adds. Publicly traded companies in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE).Reference Link

ACB

Aurora Cannabis

$9.77 /

+0.28 (+2.95%)

CGC

Canopy Growth

$27.32 /

+1.2 (+4.59%)

IGC

India Globalization Capital

$1.70 /

+0.04 (+2.42%)

CANN

General Cannabis

$0.00 /

+ (+0.00%)

ZYNE

Zynerba

$3.35 /

+0.03 (+0.90%)

CRON

Cronos Group

$7.63 /

+0.03 (+0.39%)

TLRY

Tilray

$9.39 /

+0.395 (+4.39%)

CVSI

CV Sciences

$0.00 /

+ (+0.00%)

CNTTF

CannTrust Holdings

$0.00 /

+ (+0.00%)

APHA

Aphria

$7.56 /

+0.27 (+3.70%)

TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

  • 11

    Jan

  • 11

    Jan

  • 11

    Nov

ACB Aurora Cannabis
$9.77 /

+0.28 (+2.95%)

12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
11/17/20 GLJ Research
With $0 target, GLJ says short Aurora Cannabis on recent rally
CGC Canopy Growth
$27.32 /

+1.2 (+4.59%)

01/05/21 Cantor Fitzgerald
Canopy Growth price target raised to C$33 from C$29 at Cantor Fitzgerald
12/28/20 JPMorgan
Constellation Brands price target raised to $248 from $218 at JPMorgan
12/24/20 Raymond James
Raymond James says Village Farms situated well for cannabis sector consolidation
IGC India Globalization Capital
$1.70 /

+0.04 (+2.42%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
CANN General Cannabis
$0.00 /

+ (+0.00%)

ZYNE Zynerba
$3.35 /

+0.03 (+0.90%)

12/21/20 H.C. Wainwright
Zynerba price target lowered to $9 from $12 at H.C. Wainwright
07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
CRON Cronos Group
$7.63 /

+0.03 (+0.39%)

11/16/20 Jefferies
Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
09/09/20 Stifel
Cronos CEO transition 'natural part' of company's evolution, says Stifel
TLRY Tilray
$9.39 /

+0.395 (+4.39%)

12/17/20 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
12/17/20 Stifel
Tilray upgraded to Hold from Sell at Stifel
12/17/20 Stifel
Aphria downgraded to Hold from Buy at Stifel
CVSI CV Sciences
$0.00 /

+ (+0.00%)

06/12/20 Cowen
CV Sciences initiated with a Market Perform at Cowen
CNTTF CannTrust Holdings
$0.00 /

+ (+0.00%)

APHA Aphria
$7.56 /

+0.27 (+3.70%)

12/17/20 CIBC
Aphria price target raised to C$12.50 from C$9 at CIBC
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

11/18/20 Craig-Hallum
Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
11/17/20 Alliance Global Partners
Trulieve Cannabis price target raised to C$50 from C$40 at Alliance Global

TODAY'S FREE FLY STORIES

Earnings
Perrigo sees FY21 Worldwide Consumer organic net sales growth of 3% » 07:15
03/01/21
03/01
07:15
03/01/21
07:15
PRGO

Perrigo

$40.20 /

-0.58 (-1.42%)

Management said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
10/19/20 Morgan Stanley
Morgan Stanley sees volatility in Perrigo on Irish tax litigation ruling
06/16/20 JPMorgan
Perrigo tax dispute well reflected in shares, says JPMorgan
PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

Syndicate
Royal Caribbean files to sell $1.5B in common stock » 07:14
03/01/21
03/01
07:14
03/01/21
07:14
RCL

Royal Caribbean

$93.43 /

+1.82 (+1.99%)

The Company expects to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$93.43 /

+1.82 (+1.99%)

RCL Royal Caribbean
$93.43 /

+1.82 (+1.99%)

02/24/21 Credit Suisse
Royal Caribbean price target raised to $117 from $76 at Credit Suisse
02/23/21 JPMorgan
Royal Caribbean price target raised to $100 from $91 at JPMorgan
02/23/21 Deutsche Bank
Royal Caribbean price target raised to $79 from $62 at Deutsche Bank
02/12/21 Berenberg
Royal Caribbean downgraded to Sell from Hold at Berenberg
RCL Royal Caribbean
$93.43 /

+1.82 (+1.99%)

  • 14
    Oct
RCL Royal Caribbean
$93.43 /

+1.82 (+1.99%)

RCL Royal Caribbean
$93.43 /

+1.82 (+1.99%)

RCL Royal Caribbean
$93.43 /

+1.82 (+1.99%)

Recommendations
Amneal Pharmaceuticals price target raised to $8 from $6 at Barclays » 07:14
03/01/21
03/01
07:14
03/01/21
07:14
AMRX

Amneal Pharmaceuticals

$5.40 /

+0.51 (+10.43%)

Barclays analyst Balaji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRX Amneal Pharmaceuticals
$5.40 /

+0.51 (+10.43%)

AMRX Amneal Pharmaceuticals
$5.40 /

+0.51 (+10.43%)

12/14/20 Guggenheim
Amneal Pharmaceuticals upgraded to Buy from Neutral at Guggenheim
12/14/20 Barclays
Amneal upgraded to Overweight on generic recovery at Barclays
12/14/20 Barclays
Amneal upgraded to Overweight from Equal Weight at Barclays
10/06/20 Raymond James
Generic NuvaRing opportunity remains largely Amneal's, says Raymond James
AMRX Amneal Pharmaceuticals
$5.40 /

+0.51 (+10.43%)

Earnings
Astec reports Q4 adjusted EPS 56c, consensus 42c » 07:14
03/01/21
03/01
07:14
03/01/21
07:14
ASTE

Astec

$68.01 /

-0.53 (-0.77%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASTE Astec
$68.01 /

-0.53 (-0.77%)

ASTE Astec
$68.01 /

-0.53 (-0.77%)

12/30/20 Sidoti
Astec price target raised to $64 from $58 at Sidoti
12/15/20 Stifel
Astec price target raised to $62 from $55 at Stifel
12/11/20 Baird
Astec price target raised to $71 from $47 at Baird
04/23/20 Sidoti
Astec downgraded to Neutral with $41 price target at Sidoti
ASTE Astec
$68.01 /

-0.53 (-0.77%)

Downgrade
Forterra downgraded to Sector Perform from Outperform at RBC Capital » 07:14
03/01/21
03/01
07:14
03/01/21
07:14
FRTA

Forterra

$23.30 /

+0.02 (+0.09%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRTA Forterra
$23.30 /

+0.02 (+0.09%)

FRTA Forterra
$23.30 /

+0.02 (+0.09%)

02/24/21 Citi
Forterra downgraded to Neutral from Buy at Citi
12/21/20 Credit Suisse
Forterra initiated with a Neutral at Credit Suisse
12/18/20 Barclays
Forterra price target raised to $18 from $15 at Barclays
11/25/20
Fly Intel: Top five analyst initiations
FRTA Forterra
$23.30 /

+0.02 (+0.09%)

  • 17
    Sep
FRTA Forterra
$23.30 /

+0.02 (+0.09%)

Earnings
Covetrus reports Q4 EPS (4c), consensus 16c » 07:13
03/01/21
03/01
07:13
03/01/21
07:13
CVET

Covetrus

$37.20 /

+1.17 (+3.25%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVET Covetrus
$37.20 /

+1.17 (+3.25%)

CVET Covetrus
$37.20 /

+1.17 (+3.25%)

02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Barclays
Covetrus initiated with an Overweight at Barclays
09/16/20
Fly Intel: Top five analyst upgrades
09/16/20 Stifel
Covetrus upgraded to Buy with $26 price target at Stifel
CVET Covetrus
$37.20 /

+1.17 (+3.25%)

CVET Covetrus
$37.20 /

+1.17 (+3.25%)

Earnings
Middleby reports Q4 EPS $1.62, consensus $1.41 » 07:13
03/01/21
03/01
07:13
03/01/21
07:13
MIDD

Middleby

$146.45 /

+1.71 (+1.18%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MIDD Middleby
$146.45 /

+1.71 (+1.18%)

MIDD Middleby
$146.45 /

+1.71 (+1.18%)

02/25/21
Fly Intel: Top five analyst initiations
02/25/21 JPMorgan
Middleby initiated with a Neutral at JPMorgan
01/19/21 Jefferies
Middleby upgraded to Buy from Hold at Jefferies
11/18/20 KeyBanc
Middleby price target raised to $155 from $140 at KeyBanc
MIDD Middleby
$146.45 /

+1.71 (+1.18%)

Initiation
Telus International initiated with an Outperform at RBC Capital » 07:13
03/01/21
03/01
07:13
03/01/21
07:13
TIXT

Telus International

$29.09 /

+0.09 (+0.31%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TIXT Telus International
$29.09 /

+0.09 (+0.31%)

TIXT Telus International
$29.09 /

+0.09 (+0.31%)

07:11 Today William Blair
Telus International initiated with an Outperform at William Blair
07:00 Today Citi
Telus International initiated with a Neutral at Citi
06:56 Today Credit Suisse
Telus International initiated with a Neutral at Credit Suisse
06:33 Today Barclays
Telus International initiated with an Overweight at Barclays
  • 03
    Feb
TIXT Telus International
$29.09 /

+0.09 (+0.31%)

Hot Stocks
Arvinas announces anticipated milestones, expectations » 07:13
03/01/21
03/01
07:13
03/01/21
07:13
ARVN

Arvinas

$78.42 /

+4.65 (+6.30%)

Anticipated Milestones…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
01/05/21 Cantor Fitzgerald
Arvinas price target raised to $121 from $66 at Cantor Fitzgerald
12/21/20 Piper Sandler
Arvinas price target raised to $97 from $58 at Piper Sandler
12/15/20 Roth Capital
Arvinas price target raised to $120 from $65 at Roth Capital
ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

  • 16
    Dec
ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

Initiation
Telus International initiated with an Outperform at William Blair » 07:11
03/01/21
03/01
07:11
03/01/21
07:11
TIXT

Telus International

/

+

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TIXT Telus International
/

+

TIXT Telus International
/

+

07:00 Today Citi
Telus International initiated with a Neutral at Citi
06:56 Today Credit Suisse
Telus International initiated with a Neutral at Credit Suisse
06:33 Today Barclays
Telus International initiated with an Overweight at Barclays
06:21 Today CIBC
Telus International initiated with an Outperformer at CIBC
  • 03
    Feb
TIXT Telus International
/

+

Upgrade
Spirit AeroSystems upgraded to Overweight from Underweight at Morgan Stanley » 07:11
03/01/21
03/01
07:11
03/01/21
07:11
SPR

Spirit AeroSystems

/

+

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPR Spirit AeroSystems
/

+

SPR Spirit AeroSystems
/

+

07:11 Today Morgan Stanley
Correction: Spirit AeroSystems double upgraded to Overweight at Morgan Stanley
05:24 Today Morgan Stanley
Spirit AeroSystems upgraded to Overweight from Equal Weight at Morgan Stanley
02/25/21 Cowen
Spirit AeroSystems price target raised to $55 from $46 at Cowen
01/21/21
Fly Intel: Top five analyst upgrades
SPR Spirit AeroSystems
/

+

SPR Spirit AeroSystems
/

+

SPR Spirit AeroSystems
/

+

Earnings
Perrigo reports Q4 adjusted EPS 93c, consensus $1.00 » 07:11
03/01/21
03/01
07:11
03/01/21
07:11
PRGO

Perrigo

$40.20 /

-0.58 (-1.42%)

Reports Q4 revenue $1.3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
10/19/20 Morgan Stanley
Morgan Stanley sees volatility in Perrigo on Irish tax litigation ruling
06/16/20 JPMorgan
Perrigo tax dispute well reflected in shares, says JPMorgan
PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

Hot Stocks
Arvinas expects cash to fund operating expenses into 2024 » 07:11
03/01/21
03/01
07:11
03/01/21
07:11
ARVN

Arvinas

$78.42 /

+4.65 (+6.30%)

Based on its current…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
01/05/21 Cantor Fitzgerald
Arvinas price target raised to $121 from $66 at Cantor Fitzgerald
12/21/20 Piper Sandler
Arvinas price target raised to $97 from $58 at Piper Sandler
12/15/20 Roth Capital
Arvinas price target raised to $120 from $65 at Roth Capital
ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

  • 16
    Dec
ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

Earnings
Arvinas reports Q4 EPS (99c), consensus (78c) » 07:10
03/01/21
03/01
07:10
03/01/21
07:10
ARVN

Arvinas

$78.42 /

+4.65 (+6.30%)

Reports Q4 revenue $2.2M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
01/05/21 Cantor Fitzgerald
Arvinas price target raised to $121 from $66 at Cantor Fitzgerald
12/21/20 Piper Sandler
Arvinas price target raised to $97 from $58 at Piper Sandler
12/15/20 Roth Capital
Arvinas price target raised to $120 from $65 at Roth Capital
ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

  • 16
    Dec
ARVN Arvinas
$78.42 /

+4.65 (+6.30%)

Recommendations
Welbilt price target raised to $17.00 from $8.50 at BMO Capital » 07:10
03/01/21
03/01
07:10
03/01/21
07:10
WBT

Welbilt

$16.00 /

+0.19 (+1.20%)

BMO Capital analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WBT Welbilt
$16.00 /

+0.19 (+1.20%)

WBT Welbilt
$16.00 /

+0.19 (+1.20%)

02/26/21 Baird
Welbilt price target raised to $18 from $17 at Baird
01/15/21 Barclays
Welbilt price target raised to $20 from $15 at Barclays
01/07/21 Barclays
Welbilt estimates for 2021 are too low by at least 10%, says Barclays
01/05/21 KeyBanc
Welbilt price target raised to $18 from $11 at KeyBanc
WBT Welbilt
$16.00 /

+0.19 (+1.20%)

WBT Welbilt
$16.00 /

+0.19 (+1.20%)

Syndicate
Twitter announces offering of $1.25B of convertible senior notes due 2026 » 07:10
03/01/21
03/01
07:10
03/01/21
07:10
TWTR

Twitter

$77.07 /

+2.515 (+3.37%)

Twitter announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$77.07 /

+2.515 (+3.37%)

TWTR Twitter
$77.07 /

+2.515 (+3.37%)

02/26/21 Stifel
Twitter price target raised to $70 from $60 at Stifel
02/26/21 JPMorgan
Twitter price target raised to $91 from $77 at JPMorgan
02/26/21 KeyBanc
Twitter price target raised to $90 from $80 at KeyBanc
02/26/21 Mizuho
Twitter price target raised to $67 from $57 at Mizuho
TWTR Twitter
$77.07 /

+2.515 (+3.37%)

TWTR Twitter
$77.07 /

+2.515 (+3.37%)

TWTR Twitter
$77.07 /

+2.515 (+3.37%)

TWTR Twitter
$77.07 /

+2.515 (+3.37%)

Hot Stocks
Flowserve supports Pfizer in production of COVID-19 vaccine » 07:10
03/01/21
03/01
07:10
03/01/21
07:10
FLS

Flowserve

$37.03 /

-0.68 (-1.80%)

, PFE

Pfizer

$33.49 /

-0.335 (-0.99%)

Flowserve (FLS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLS Flowserve
$37.03 /

-0.68 (-1.80%)

PFE Pfizer
$33.49 /

-0.335 (-0.99%)

FLS Flowserve
$37.03 /

-0.68 (-1.80%)

02/25/21 Citi
Flowserve price target raised to $44 from $42 at Citi
01/04/21 Credit Suisse
Flowserve downgraded to Neutral from Outperform at Credit Suisse
12/15/20
Fly Intel: Top five analyst upgrades
12/15/20 Stifel
Flowserve upgraded to Buy at Stifel ahead of expected multiple expansion
PFE Pfizer
$33.49 /

-0.335 (-0.99%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
02/03/21 Mizuho
Pfizer price target lowered to $42 from $44 at Mizuho
FLS Flowserve
$37.03 /

-0.68 (-1.80%)

PFE Pfizer
$33.49 /

-0.335 (-0.99%)

PFE Pfizer
$33.49 /

-0.335 (-0.99%)

FLS Flowserve
$37.03 /

-0.68 (-1.80%)

PFE Pfizer
$33.49 /

-0.335 (-0.99%)

FLS Flowserve
$37.03 /

-0.68 (-1.80%)

PFE Pfizer
$33.49 /

-0.335 (-0.99%)

Initiation
On24 initiated with an Outperform at William Blair » 07:10
03/01/21
03/01
07:10
03/01/21
07:10
ONTF

On24

$56.34 /

+0.85 (+1.53%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONTF On24
$56.34 /

+0.85 (+1.53%)

06:04 Today Piper Sandler
On24 initiated with an Overweight at Piper Sandler
02/28/21 Goldman Sachs
On24 initiated with a Buy at Goldman Sachs
  • 03
    Feb
ONTF On24
$56.34 /

+0.85 (+1.53%)

Hot Stocks
FDA requests new study from Athenex for oral paclitaxel plus encequidar » 07:08
03/01/21
03/01
07:08
03/01/21
07:08
ATNX

Athenex

$12.18 /

+0.29 (+2.44%)

Athenex announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATNX Athenex
$12.18 /

+0.29 (+2.44%)

ATNX Athenex
$12.18 /

+0.29 (+2.44%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Evercore ISI
Athenex initiated with an Outperform at Evercore ISI
10/26/20
Fly Intel: Top five analyst initiations
10/26/20 SVB Leerink
Athenex initiated with an Outperform at SVB Leerink
ATNX Athenex
$12.18 /

+0.29 (+2.44%)

  • 10
    Sep
ATNX Athenex
$12.18 /

+0.29 (+2.44%)

Hot Stocks
Amicus sees FY21 total Galafold revenue $300M-$315M » 07:07
03/01/21
03/01
07:07
03/01/21
07:07
FOLD

Amicus

$12.27 /

+0.34 (+2.85%)

Double-digit revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$12.27 /

+0.34 (+2.85%)

FOLD Amicus
$12.27 /

+0.34 (+2.85%)

02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
02/12/21 Cantor Fitzgerald
Amicus downgraded to Neutral from Overweight at Cantor Fitzgerald
FOLD Amicus
$12.27 /

+0.34 (+2.85%)

FOLD Amicus
$12.27 /

+0.34 (+2.85%)

FOLD Amicus
$12.27 /

+0.34 (+2.85%)

FOLD Amicus
$12.27 /

+0.34 (+2.85%)

Earnings
Amicus reports FY20 EPS ($1.07), consensus ($1.02) » 07:07
03/01/21
03/01
07:07
03/01/21
07:07
FOLD

Amicus

$12.27 /

+0.34 (+2.85%)

Reports FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$12.27 /

+0.34 (+2.85%)

FOLD Amicus
$12.27 /

+0.34 (+2.85%)

02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
02/12/21 Cantor Fitzgerald
Amicus downgraded to Neutral from Overweight at Cantor Fitzgerald
FOLD Amicus
$12.27 /

+0.34 (+2.85%)

FOLD Amicus
$12.27 /

+0.34 (+2.85%)

FOLD Amicus
$12.27 /

+0.34 (+2.85%)

FOLD Amicus
$12.27 /

+0.34 (+2.85%)

Hot Stocks
Perrigo to sell Generic Rx business to Altaris Capital Partners for $1.55B » 07:07
03/01/21
03/01
07:07
03/01/21
07:07
PRGO

Perrigo

$40.20 /

-0.58 (-1.42%)

Perrigo announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
10/19/20 Morgan Stanley
Morgan Stanley sees volatility in Perrigo on Irish tax litigation ruling
06/16/20 JPMorgan
Perrigo tax dispute well reflected in shares, says JPMorgan
PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

Recommendations
South Jersey Industries price target raised to $26 from $25 at Mizuho » 07:06
03/01/21
03/01
07:06
03/01/21
07:06
SJI

South Jersey Industries

$25.14 /

-0.42 (-1.64%)

Mizuho analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SJI South Jersey Industries
$25.14 /

-0.42 (-1.64%)

SJI South Jersey Industries
$25.14 /

-0.42 (-1.64%)

12/17/20 Stifel
South Jersey Industries initiated with a Hold at Stifel
07/24/20
Fly Intel: Top five analyst initiations
07/23/20 Mizuho
South Jersey Industries initiated with a Neutral at Mizuho
07/01/20 JPMorgan
South Jersey Industries downgraded to Underweight with $25 target at JPMorgan
SJI South Jersey Industries
$25.14 /

-0.42 (-1.64%)

Earnings
Evertec sees FY21 adjusted EPS $2.15-$2.23, consensus $2.28 » 07:06
03/01/21
03/01
07:06
03/01/21
07:06
EVTC

Evertec

$38.90 /

+1.215 (+3.22%)

Sees FY 21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVTC Evertec
$38.90 /

+1.215 (+3.22%)

EVTC Evertec
$38.90 /

+1.215 (+3.22%)

11/12/20 Goldman Sachs
Evertec price target raised to $38 from $33 at Goldman Sachs
10/05/20 Stephens
Evertec a 'less likely' target if Global Payments seeks deals, says Stephens
09/17/20 Susquehanna
Evertec LBO estimated to be in $40-$45 range, says Susquehanna
08/05/20 Susquehanna
Evertec price target raised to $38 from $33 at Susquehanna
EVTC Evertec
$38.90 /

+1.215 (+3.22%)

EVTC Evertec
$38.90 /

+1.215 (+3.22%)

Recommendations
Novocure price target raised to $175 from $150 at Mizuho » 07:06
03/01/21
03/01
07:06
03/01/21
07:06
NVCR

Novocure

$149.20 /

+0.32 (+0.21%)

Mizuho analyst Difei Yang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$149.20 /

+0.32 (+0.21%)

NVCR Novocure
$149.20 /

+0.32 (+0.21%)

02/25/21 Piper Sandler
'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler
01/29/21 Truist
Novocure price target raised to $132 from $118 at Truist
01/25/21 Piper Sandler
Novocure price target raised to $225 from $140 at Piper Sandler
01/12/21 Wedbush
Novocure price target raised to $159 from $110 at Wedbush
NVCR Novocure
$149.20 /

+0.32 (+0.21%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.